Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Stopped Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period

Conditions

• Systemic Lupus Erythematosus

Interventions

• DRUG: Corticosteroids (prednisone or prednisolone)
• DRUG: Abatacept
• DRUG: Abatacept
• DRUG: Mycophenolate mofetil (MMF)
• DRUG: Abatacept

Sponsor

Bristol-Myers Squibb